Laboratoire de Biophotonique et Pharmacologie
UMR CNRS 7213


Partenaires

CNRS
Logo Universite de strasbourg
 

Rechercher

Sur ce site

Sur le Web du CNRS


Accueil du site > Equipe Pharmacologie expérimentale et thérapeutique > Publications

Publication 2014

22 janvier 2016

N. AUBERVAL, S. DAL, W. BIETIGER, M. PINGET, N. JEANDIDIER, E. MAILLARD-PETRACINI, V.B. SCHINI-KERTH & S. SIGRIST. Metabolic and oxidative stress markers in Wistar rats after 2 months on a high-fat diet. Diabetol. Metab. Syndr. 6, 130, 2014 – IF 2.17 – EQ3

Y. BARATLI, A.L. CHARLES, V. WOLFF, L. BEN TAHAR, L. SMIRI, J. BOUITBIR, J. ZOLL, M. SAKLY, C. AUGER, T. VOGEL, H. ABDELMELEK, O. TEBOURBI & B. GENY. Age modulates Fe3O4 nanoparticles liver toxicity : dose-dependent decrease in mitochondrial respiratory chain complexes activities and coupling in middle-aged as compared to young rats. BioMed Res. Int. 2014, 474081, 2014 – IF 1.58 – EQ3

J. BOISRAMÉ-HELMS, X. DELABRANCHE, S.E. DEGIRMENCI, F. ZOBAIRI, A. BERGER, G. MEYER, M. BURBAN, H.A. MOSTEFAI, B. LEVY, F. TOTI & F. MEZIANI. Pharmacological modulation of procoagulant microparticles improves haemodynamic dysfunction during septic shock in rats. Thromb. Haemost. 111, 154-164, 2014 – IF 4.98 – EQ3

J. BOISRAMÉ-HELMS, X. DELABRANCHE, A. KLYMCHENKO, J. DRAI, E. BLOND, F. ZOBAIRI, Y. MELY, M. HASSELMANN, F. TOTI & F. MEZIANI. Lipid emulsions differentially affect LPS-induced acute monocytes inflammation : in vitro effects on membrane remodeling and cell viability. Lipids 49, 1091-1099, 2014 – IF 1.85 – EQ1-EQ3

J. BOISRAME-HELMS, A. SAID, M. BURBAN, X. DELABRANCHE, F. ZOBAIRI, M. HASSELMANN, V.B. SCHINI-KERTH, F. TOTI & F. MEZIANI. Medium-chain triglycerides supplementation exacerbates peritonitis-induced septic shock in rats : role on cell membrane remodeling. Shock 42, 548-553, 2014 – IF 3.04 – EQ3

A.A. CONSTANTINESCU, C. GLEIZES, M. ALHOSIN, E. YALA, F. ZOBAIRI, A. LECLERCQ, G. STOIAN, I.L. MITREA, G. PRÉVOST, F. TOTI & L. KESSLER. Exocrine cell-derived microparticles in response to lipppolysaccharide promote endocrine dysfunction in cystic fibrosis. J. Cyst. Fibros. 13, 219-226, 2014 – IF 3.47 – EQ3

F. EMHEMMED, S. ALI AZOUAOU, F. THUAND, V. SCHINI-KERTH, L. DESAUBRY, C.D. MULLER & G. FUHRMANN. Selective anticancer effects of a synthetic flavagline on human Oct4-expressing cancer stem-like cells via a p38 MAPK-dependent caspase-3-dependent pathway. Biochem. Pharmacol. 89, 185-196, 2014 – IF 5.01 – EQ3

C. GLEIZES, A. CONSTANTINESCU, M. ABBAS, H. BOUHADJA, F. ZOBAIRI, L. KESSLER & F. TOTI. Liraglutide protects Rin-m5f beta cells by reducing procoagulant tissue factor activity and apoptosis prompted by microparticles under conditions mimicking instant blood-mediated inflammatory reaction. Transpl. Int. 27, 733-740, 2014 – IF 2.60 – EQ3

L. JESEL, T. ARENTZ, C. HERRERA-SIKLODY, D. TRENK, F. ZOBAIRI, M. ABBAS, R. WEBER, J. MINNERS, F. TOTI & O. MOREL. Do atrial differences in endothelial damage, leukocyte and platelet activation, or tissue factor activity contribute to chamber-specific thrombogenic status in patients with atrial fibrillation ? J. Cardiovasc. Electrophysiol. 25, 266-270, 2014 – IF 3.16 – EQ3

J.H. KIM, C. AUGER & V.B. SCHINI-KERTH. Activation of eNOS by polyphenol-rich products and polyphenolic compounds. Curr. Pharm. Design 20, 3521-3529, 2014 – IF 3.45 – EQ3

S.K. RASHID, N. IDRIS KHODJA, C. AUGER, M. ALHOSIN, N. BOEHM, M. OSWALD-MAMMOSSER & V.B. SCHINI-KERTH. Probiotics (VSL#3) prevent endothelial dysfunction in rats with portal hypertension : role of the angiotensin system. PLoS One 9, e97458, 2014 – IF 3.23 – EQ3

J.C. TAM, C.H. KO, K.M. LAU, M.H. TO, H.F. KWOK, Y.W. CHAN, W.S. SIU, N. ETIENNE-SELLOUM, C.P. LAU, W.Y. CHAN, P.C. LEUNG, K.P. FUNG, V.B. SCHINI-KERTH & C.B. LAU. A Chinese 2-herb formula (NF3) promotes hindlimb ischemia-induced neovascularization and wound healing of diabetic rats. J. Diabetes Complications 28, 436-447, 2014 – IF 3.00 – EQ2-EQ3

F. ZGHEEL, M. ALHOSIN, S. RASHID, M. BURBAN, C. AUGER & V.B. SCHINI-KERTH. Redox-sensitive induction of Src/PI3-kinase/Akt and MAPKs pathways activate eNOS in response to EPA:DHA 6:1. PLoS One 9, e105102, 2014 – IF 3.23 – EQ3